EFEGATRAN

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H32N6O3
Molecular Weight	416.5172
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN[C@H](CC1=CC=CC=C1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(N)=N)C=O

InChI

InChIKey=KAGLWQUWUNBAOO-KSZLIROESA-N

InChI=1S/C21H32N6O3/c1-24-17(13-15-7-3-2-4-8-15)20(30)27-12-6-10-18(27)19(29)26-16(14-28)9-5-11-25-21(22)23/h2-4,7-8,14,16-18,24H,5-6,9-13H2,1H3,(H,26,29)(H4,22,23,25)/t16-,17+,18-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C21H32N6O3
Molecular Weight	416.5172
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2342067 | https://www.ncbi.nlm.nih.gov/pubmed/1641823 | https://www.ncbi.nlm.nih.gov/pubmed/1641827 | https://www.ncbi.nlm.nih.gov/pubmed/16001314 | https://adisinsight.springer.com/drugs/800001951

Efegatran (GYKI 14766; LY 294468) is a tripeptide D-methyl-phenylalanyl-prolyl-arginal thrombin inhibitor. It was developed by IVAX for the potential treatment of thromboembolic disorders, mainly myocardial infarction. However, information about the further development is not available.

Originator

Approval Year

PubMed

Title	Date	PubMed

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 16:16:03 GMT 2023` Edited by `admin` on `Sat Dec 16 16:16:03 GMT 2023`
Record UNII	VT0VK2474K
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

EFEGATRAN

Official Name

English

LY294468

Code

English

L-PROLINAMIDE, N-METHYL-D-PHENYLALANYL-N-(4-((AMINOIMINOMETHYL)AMINO)-1-FORMYLBUTYL)-, (S)-

Systematic Name

English

LY-294468

Code

English

efegatran [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C783